Trial Profile
Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2013
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Generalised anxiety disorder
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly and Company
- 01 Nov 2011 Results published in the Chinese Medical Journal.
- 06 Jul 2010 Registrational comment added and comment about regulatory requirement.
- 06 Jun 2010 Patient recruitment details and results were presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum. Results of the study were not provided in the abstract.